Zobrazeno 1 - 7
of 7
pro vyhledávání: '"capsid particle concentration"'
Autor:
James Z. Deng, Richard R. Rustandi, Andrew Swartz, Yvonne Shieh, Jack B. Baker, Josef Vlasak, Shiyi Wang, John W. Loughney
Publikováno v:
Molecular Therapy: Oncolytics, Vol 24, Iss , Pp 139-147 (2022)
V937 is an oncolytic virus immunotherapy clinical drug candidate consisting of a proprietary formulation of Coxsackievirus A21 (CVA21). V937 specifically binds to and lyses cells with over-expressed ICAM-1 receptors in a range of tumor cell types and
Externí odkaz:
https://doaj.org/article/b954560e8b3b4c5d9fc9912ac8f9cb14
Autor:
James Z. Deng, Richard R. Rustandi, Andrew Swartz, Yvonne Shieh, Jack B. Baker, Josef Vlasak, Shiyi Wang, John W. Loughney
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 24, Iss, Pp 139-147 (2022)
Molecular Therapy: Oncolytics, Vol 24, Iss, Pp 139-147 (2022)
V937 is an oncolytic virus immunotherapy clinical drug candidate consisting of a proprietary formulation of Coxsackievirus A21 (CVA21). V937 specifically binds to and lyses cells with over-expressed ICAM-1 receptors in a range of tumor cell types and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c103f8e5c9b3e5c5120a39b6bdc6888a
https://pubmed.ncbi.nlm.nih.gov/35024440
https://pubmed.ncbi.nlm.nih.gov/35024440
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deng, James Z., Rustandi, Richard R., Barbacci, Damon, Swartz, Andrew R., Gulasarian, Amanda, Loughney, John W.
Publikováno v:
Human Gene Therapy; Jul2022, Vol. 33 Issue 13/14, p765-775, 11p
Autor:
Vellekamp, Gary, Porter, Frederick W., Sutjipto, Suganto, Cutler, Collette, Bondoc, Larry, Liu, Yan-Hui, Wylie, David, Cannon-Carlson, Susan, Tang, John T., Frei, Andreas, Voloch, Marcio, Zhuang, Shaobin
Publikováno v:
Human Gene Therapy; October 10, 2001, Vol. 12 Issue: 15 p1923-1936, 14p
SEC coupled with in-line multiple detectors for the characterization of an oncolytic Coxsackievirus.
Autor:
Deng JZ; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Rustandi RR; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Swartz A; Process Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Shieh Y; Process Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Baker JB; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Vlasak J; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Wang S; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA., Loughney JW; Analytical Research & Development, Merck & Co., Kenilworth, NJ 07033, USA.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2021 Dec 11; Vol. 24, pp. 139-147. Date of Electronic Publication: 2021 Dec 11 (Print Publication: 2022).
Autor:
Larry Bondoc, Vellekamp Gary J, Marcio Voloch, Suganto Sutjipto, Susan Cannon-Carlson, Wylie David C, Frei Andreas, Shaobin Zhuang, Yan-Hui Liu, Frederick William Porter, Collette M. Cutler, John T. Tang
Publikováno v:
Human gene therapy. 12(15)
Empty capsids from adenovirus, that is, virus particles lacking DNA, are well documented in the published literature. They can be separated from complete virus by CsCl density gradient centrifugation. Here we characterize the presence of empty capsid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8fee92db506daed2a8dc2a7ff87b564
https://pubmed.ncbi.nlm.nih.gov/11589834
https://pubmed.ncbi.nlm.nih.gov/11589834